Yatırımcı.AI

HBV vs RRA Fund Comparison

Price, period returns, size, investor count and risk score of HBV (Hedef Portföy Doruk Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and RRA (Rota Portföy Para Piyasası Serbest Fon) side by side.

SPK decided to liquidate HBV in bulletin 2026/60 dated September 17, 2026; no buy or redemption orders are executed in the fund. Its returns in this comparison are based on the last price published on TEFAS (September 29, 2026). HBV fund page · SPK bulletin 2026/60

HBVRRA
StockFund

If You Had Invested TRY 10,000

Metric Comparison

HBV vs RRA Fund Comparison
MetricHBVRRACategory median
Daily−4.71%0.11%−0.07%
1 week−1.02%0.72%−0.29%
1 month−14.79%3.21%0.00%
3 months−2.00%9.77%4.33%
6 months23.60%21.47%11.90%
YTD62.54%33.73%14.97%
1 year53.38%48.29%21.27%
3 years108.46%—111.30%
Returns are based on prices as of September 29, 2026; the fund with the higher return or the lower risk score counts as the leader.

Popular Comparisons

Popular Fund Comparisons

Related Pages

About the HBV vs RRA Comparison

The price, returns, size and risk of HBV (Hedef Portföy Doruk Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and RRA (Rota Portföy Para Piyasası Serbest Fon) are compared side by side as of September 29, 2026. Of the 10 metrics compared, HBV leads in 4 and RRA leads in 6. HBV is a Hedge Fund fund managed by Hedef Portföy Yönetimi A.Ş.; RRA is a Hedge Fund fund managed by Rota Portföy Yönetimi A.Ş..

Highlights: Daily: RRA leads (0.11% vs −4.71%). 1 week: RRA leads (0.72% vs −1.02%). 1 month: RRA leads (3.21% vs −14.79%). 3 months: RRA leads (9.77% vs −2.00%). 6 months: HBV leads (23.60% vs 21.47%). YTD: HBV leads (62.54% vs 33.73%). 1 year: HBV leads (53.38% vs 48.29%). Size (TRY): HBV leads (966.6M vs 952.8M). Investors: RRA leads (128 vs 17). Risk: RRA leads (2 vs 7).

Frequently Asked Questions

Year to date HBV returned 62.54% and RRA returned 33.73%; over the last year HBV returned 53.38% and RRA returned 48.29%. Over the last month HBV returned −14.79% and RRA returned 3.21%. Past performance does not indicate future returns.

As of September 29, 2026, HBV has a size of TRY 966.6M with 17 investors, while RRA has a size of TRY 952.8M with 128 investors. HBV leads in size and RRA leads in investor count.

The CMB risk score of HBV is 7 out of 7 and that of RRA is 2. The risk score reflects the historical volatility of the fund price; 1 is the lowest and 7 the highest risk. A lower score means less volatility, not a guarantee of higher returns.